Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NETRIS Pharma

Explore full profile

Monoclonal antibodies overcoming cancer therapy resistance.

Lyon, FranceFounded 2008Biotech & Life Sciences
Valuation $25–50M Last recorded · 2023
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for NETRIS Pharma and the history behind them.

About NETRIS Pharma

Operator of a biopharmaceutical company intended to drive superior clinical benefits for patients in the treatment of cancer. The company's therapies work by targeting the dependence receptors to effectively restore the dependence receptor apoptosis signaling pathway in the absence of the required stimulus, enabling physicians and doctors to effectively cure cancers. Keywords: Pharmaceuticals and Biotechnology, Cancer Therapy, Cancer Treatment, Epithelial To Mesenchymal, Oncology Cure, Oncology Drug, Resistance To Treatment, Therapeutic Drug, Therapeutic Molecules, Therapy Research.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Lyon, France
Sector
Biotech & Life Sciences

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • European Innovation Council
  • Horizon Europe

Series A1 investor entered at this stage

  • EIC Fund
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇫🇷 France71.4%
🇨🇭 Switzerland21.4%
🇺🇸 United States7.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NETRIS Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NETRIS Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.